المؤلفون: Patrick Schöffski, Suzanne George, Michael C. Heinrich, John R. Zalcberg, Sebastian Bauer, Hans Gelderblom, César Serrano, Robin L. Jones, Steven Attia, Gina D’Amato, Ping Chi, Peter Reichardt, Claus Becker, Kelvin Shi, Julie Meade, Rodrigo Ruiz-Soto, Jean-Yves Blay, Margaret von Mehren

المساهمون: Institut Català de la Salut, [Schöffski P] General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. [George S] Dana-Farber Cancer Institute, Boston, MA, USA. [Heinrich MC] VA Portland Veterans Health Care System, Portland, OR, USA. OHSU Knight Cancer Institute, Portland, OR, USA. [Zalcberg JR] Monash University and Alfred Health, VIC 3004 Melbourne, Australia. [Bauer S] Department of Medical Oncology, University Hospital Essen, Sarcoma Center/ West German Cancer Center, University Duisburg-Essen, Essen, Germany. Leiden University Medical Center, Leiden, Netherlands. [Gelderblom H] Leiden University Medical Center, Leiden, Netherlands. [Serrano C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
BMC Cancer, 22(1). BMC

مصطلحات موضوعية: Quality of life, Cancer Research, Gastrointestinal Stromal Tumors, Pacients - Satisfacció, Ripretinib, Medizin, Tub digestiu - Tumors - Tractament, Medicaments antineoplàstics - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Genetics, Humans, Gastrointestinal stromal tumors, Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires::Health Care Surveys::Patient Reported Outcome Measures [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Patient Reported Outcome Measures, Other subheadings::/therapeutic use [Other subheadings], enfermedades del sistema digestivo::neoplasias del sistema digestivo::neoplasias gastrointestinales::enfermedades del sistema digestivo::tumores del estroma gastrointestinal [ENFERMEDADES], técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios::encuestas sobre atención a la salud::medidas de resultados percibidos por los pacientes [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Otros calificadores::/uso terapéutico [Otros calificadores], acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS], Alopecia, Oncology, Patient-reported outcome measures, Digestive System Diseases::Digestive System Neoplasms::Gastrointestinal Neoplasms::Digestive System Diseases::Gastrointestinal Stromal Tumors [DISEASES], Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS]

وصف الملف: application/pdf; Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::918b70199c21a3243bf387b0bcfa7aeeTest
https://doi.org/10.1186/s12885-022-10379-9Test

المؤلفون: Antonio Lopez-Pousa, Jordi Rosell, Ana Vivancos, Joaquín Arribas, Alfonso García-Valverde, Javier Martin-Broto, Sergi Quiroga, Stefania Landolfi, Jonathan A. Fletcher, Joan Carles, Ana Sebio, Miriam Sansó, Francesco M. Mancuso, Judith Matito, César Serrano, Cristina Dopazo, Sandra Castro, Suzanne George, Claudia Valverde, Anna C. Virgili, María M. Menso

المساهمون: Fundación Fero, Asociación Española Contra el Cáncer, Instituto de Salud Carlos III, Fundació Privada Cellex, Institut Català de la Salut, [Serrano C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Vivancos A, Matito J, Mancuso FM, Sansó M] Cancer Genomics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [López-Pousa A] Medical Oncology, Sant Pau University Hospital, Barcelona, Spain. [Valverde C, Carles J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Quiroga S] Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Landolfi S] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Castro S, Dopazo C] Servei de Cirurgia Oncològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [García-Valverde A, Rosell J] Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Arribas J] Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: BMC Cancer
Digital.CSIC. Repositorio Institucional del CSIC
instname
BMC CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Scientia
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Medicaments antineoplàstics - Ús terapèutic, Polymerase Chain Reaction, Circulating Tumor DNA, chemistry.chemical_compound, 0302 clinical medicine, Sunitinib, Medicine, Digital polymerase chain reaction, Molecular Targeted Therapy, Stromal tumor, Neoplasm Metastasis, Regorafenib, Tumors de parts toves, GiST, High-Throughput Nucleotide Sequencing, KIT, Sarcoma, Exons, Amplicon, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Tumor Burden, PDGFRA, Oncology, 030220 oncology & carcinogenesis, Female, Gastrointestinal stromal tumor, Cell-Free Nucleic Acids, medicine.drug, Research Article, Adult, Genotype, Gastrointestinal Stromal Tumors, neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido conjuntivo::tumores del estroma gastrointestinal [ENFERMEDADES], Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Connective Tissue::Gastrointestinal Stromal Tumors [DISEASES], lcsh:RC254-282, nucleótidos y nucleósidos de ácidos nucleicos::ácidos nucleicos::ácidos nucleicos libres de células::ADN tumoral circulante [COMPUESTOS QUÍMICOS Y DROGAS], 03 medical and health sciences, Genetics, Biomarkers, Tumor, Humans, Liquid biopsy, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], neoplasms, Protein Kinase Inhibitors, Seqüència de nucleòtids, Aged, Circulating tumor DNA, Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::Cell-Free Nucleic Acids::Circulating Tumor DNA [CHEMICALS AND DRUGS], business.industry, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], digestive system diseases, 030104 developmental biology, chemistry, Imatinib, Mutation, Cancer research, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9684fefafcf6d9eb640148a11bb98bb4Test
http://europepmc.org/articles/PMC7003348Test

المؤلفون: Laia Trigueros-Motos, Marçal Pastor-Anglada, Sandra Pérez-Torras, F. Javier Casado, Miriam Molina-Arcas

المساهمون: Universitat de Barcelona

المصدر: BMC Cancer, Vol 12, Iss 1, p 434 (2012)
BMC Cancer
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Recercat. Dipósit de la Recerca de Catalunya
Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: Cyclin-Dependent Kinase Inhibitor p21, Cancer Research, Cell cycle checkpoint, Cell Survival, Blotting, Western, Antineoplastic Agents, Apoptosis, Biology, Deoxycytidine, lcsh:RC254-282, Medicaments antineoplàstics, chemistry.chemical_compound, Cell Line, Tumor, Antineoplastic agents, Genetics, Humans, Cytotoxic T cell, fas Receptor, Cell Size, Oligonucleotide Array Sequence Analysis, Aquaporin 3, Dose-Response Relationship, Drug, Reverse Transcriptase Polymerase Chain Reaction, Cell growth, Nucleosides, Cell Cycle Checkpoints, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Gemcitabine, Molecular biology, Up-Regulation, Gene Expression Regulation, Neoplastic, Oncology, chemistry, Pharmacogenetics, Cell culture, Cancer cell, Farmacogenètica, MCF-7 Cells, Cancer research, RNA Interference, Fluorouracil, Growth inhibition, Floxuridine, HT29 Cells, Research Article

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::228fbc5bd86d4f03fded0cf8b0e5adffTest
http://www.biomedcentral.com/1471-2407/12/434Test